Cowen and Company’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-123,783
| Closed | -$7.27M | – | 759 |
|
|
2023
Q4 | $7.27M | Buy |
+123,783
| New | +$7.27M | 0.48% | 37 |
|
|
2022
Q2 | – | Sell |
-2,483
| Closed | -$204K | – | 671 |
|
|
2022
Q1 | $204K | Sell |
2,483
-3,175
| -56% | -$261K | 0.02% | 203 |
|
|
2021
Q4 | $830K | Buy |
+5,658
| New | +$830K | 0.08% | 164 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 525 |
|
|
2021
Q2 | – | Sell |
-20,324
| Closed | -$3.48M | – | 525 |
|
|
2021
Q1 | $3.48M | Buy |
+20,324
| New | +$3.48M | 0.24% | 37 |
|
|
2020
Q4 | – | Sell |
-4,101
| Closed | -$681K | – | 359 |
|
|
2020
Q3 | $681K | Buy |
+4,101
| New | +$681K | 0.11% | 98 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 342 |
|
|
2020
Q1 | – | Sell |
-19,938
| Closed | -$2.57M | – | 382 |
|
|
2019
Q4 | $2.57M | Buy |
+19,938
| New | +$2.57M | 0.22% | 43 |
|